Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin & Niazirin

被引:10
作者
Dwivedi, Gaurav R. [1 ,5 ]
Maurya, Anupam [2 ,6 ]
Yadav, Dharmendra K. [3 ,7 ]
Khan, Feroz [3 ]
Gupta, Mahendra K. [4 ]
Gupta, Prashant [4 ]
Darokar, Mahendra P. [1 ]
Srivastava, Santosh K. [2 ]
机构
[1] Cent Inst Med & Aromat Plants, CSIR, Mol Bioprospect Dept, PO CIMAP,Kukrail Picn Spot Rd, Lucknow 226015, Uttar Pradesh, India
[2] Cent Inst Med & Aromat Plants, CSIR, Med Chem Dept, Lucknow 226015, Uttar Pradesh, India
[3] Cent Inst Med & Aromat Plants, CSIR, Metab & Struct Biol, Lucknow 226015, Uttar Pradesh, India
[4] King George Med Univ, Dept Microbiol, Lucknow, Uttar Pradesh, India
[5] ICMR Reg Med Res Ctr, Microbiol Dept, Bhubaneswar 751023, Odisha, India
[6] PCIM&H, PLIM Campus, Ghaziabad 201002, India
[7] Gachon Univ, Coll Pharm, Hambakmoeiro 191, Incheon 406799, South Korea
关键词
MDR; Glycosides; Niaziridin; Niazirin; Antibacterial combinations; Drug resistance; MULTIDRUG EFFLUX PUMPS; DOCKING BASED SEMISYNTHESIS; IN-VITRO EVALUATION; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ACID-DERIVATIVES; ANTIBIOTIC-RESISTANCE; ANTIBACTERIAL DRUGS; MORINGA-OLEIFERA; INHIBITORS;
D O I
10.2174/1568026619666190412120008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Due to the limited availability of antibiotics, Gram-negative bacteria (GNB) acquire different levels of drug resistance. It raised an urgent need to identify such agents, which can reverse the phenomenon of drug resistance. Objective: To understand the mechanism of drug resistance reversal of glycosides; niaziridin and niazirin isolated from the pods of Moringa oleifera and ouabain (control) against the clinical isolates of multidrug-resistant Escherichia coli. Methods: The MICs were determined following the CLSI guidelines for broth micro-dilution. In-vitro combination studies were performed by broth checkerboard method followed by Time-Kill studies, the efflux pump inhibition assay, ATPase inhibitory activity, mutation prevention concentration and in-silico studies. Results: The results showed that both glycosides did not possess antibacterial activity of their own, but in combination, they reduced the MIC of tetracycline up to 16 folds. Both were found to inhibit efflux pumps, but niaziridin was the best. In real time expression pattern analysis, niaziridin was also found responsible for the down expression of the two important efflux pump acrB & you genes alone as well as in combination. Niaziridin was also able to over express the porin forming genes (ompA & ompX). These glycosides decreased the mutation prevention concentration of tetracycline. Conclusion: This is the first ever report on glycosides, niazirin and niaziridin acting as drug resistance reversal agent through efflux pump inhibition and modulation of expression pattern drug resistant genes. This study may be helpful in preparing an effective antibacterial combination against the drug-resistant GNB from a widely growing Moringa oleifera.
引用
收藏
页码:847 / 860
页数:14
相关论文
共 97 条
[1]   Colistin Use in Neonates and Children With Infections Due to Carbapenem-resistant Bacteria [J].
Antachopoulos, Charalampos ;
Iosifidis, Elias .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (09) :905-907
[2]   Development of novel antibacterial drugs to combat multiple resistant organisms [J].
Bassetti, Matteo ;
Righi, Elda .
LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (02) :153-165
[3]   The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system [J].
Blaustein, Mordecai P. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2018, 314 (01) :C3-C26
[4]   Antimicrobial resistance in bacteria [J].
Bockstael, Katrijn ;
Van Aerschot, Arthur .
CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2009, 4 (02) :141-155
[5]   Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF) [J].
Bohnert, Juergen A. ;
Schuster, Sabine ;
Faehnrich, Eva ;
Trittler, Rainer ;
Kern, Winfried V. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) :1216-1222
[6]   A review of cardiac glycosides: Structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential [J].
Botelho, Ana Flavia M. ;
Pierezan, Felipe ;
Soto-Blanco, Benito ;
Melo, Marilia Martins .
TOXICON, 2019, 158 :63-68
[7]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12
[8]   Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003 [J].
Chevalier, Jacqueline ;
Mulfinger, Celine ;
Garnotel, Eric ;
Nicolas, Pierre ;
Davin-Regli, Anne ;
Pages, Jean-Marie .
PLOS ONE, 2008, 3 (09)
[9]   Anti-infective potential of natural products: How to develop a stronger in vitro 'proof-of-concept' [J].
Cos, Paul ;
Vlietinck, Arnold J. ;
Vanden Berghe, Dirk ;
Maes, Louis .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 106 (03) :290-302
[10]   Combination drugs, an emerging option for antibacterial therapy [J].
Cottarel, Guillaume ;
Wierzbowski, Jamey .
TRENDS IN BIOTECHNOLOGY, 2007, 25 (12) :547-555